Advertisement

Payer

Blue Cross Blue Shield of Vermont has filed a federal lawsuit accusing Teva Pharmaceuticals of acting anticompetitively to force health insurers to pay billions of dollars for its "excessively priced" multiple sclerosis drug, Copaxone, Law Street Media reported Aug. 22. 

Blue Shield of California President and CEO Paul Markovich told America's Health Insurance Plans Aug. 22 that three critical issues must be addressed by healthcare delivery systems to make them more effective in meeting consumer needs. 

Advertisement

Michigan Gov. Gretchen Whitmer sent a letter Aug. 18 to the Michigan Department of Insurance and Financial Services that requires all payers in the state to lower their already filed 2023 health insurance rates.

Advertisement